NCT03409666View on ClinicalTrials.gov

Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions
Hip OsteoarthritisNoninflammatory Degenerative Joint DiseaseAvascular NecrosisCorrection of Functional DeformityRheumatoid Arthritis
Interventions
DEVICE

Taperloc Complete Microplasty stem

Total hip replacement with Taperloc Complete Microplasty stem and G7 acetabular shell with E1 liner

DEVICE

Taperloc Complete Reduced Distal stem

Total hip replacement with Taperloc Complete Reduced Distal stem and G7 acetabular shell with E1 liner

Trial Locations (1)

Unknown

Bravis, Roosendaal

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT03409666 - Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty. | Biotech Hunter | Biotech Hunter